Novanta Inc (NOVT) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally.

Total Assets Chart for Novanta Inc

Novanta Inc (NOVT) total assets for FY2025 were USD 1.8B, a 30.1% change from FY2024. Novanta Inc's total assets grew from USD 152.5M in 1998 to USD 1.8B in 2025 (1085.0% over 27 years). Total assets compound annual growth rate: 5-year CAGR of 15.9%, 10-year CAGR of 15.8%, 20-year CAGR of 8.2%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$5.64B
Implied Share Price
$149.10
Enterprise Value
$5.21B
Revenue (TTM)
$1.03B
EBITDA
$180.95M
Profit Margin
6.00%
Trailing P/E
94.37
Forward P/E
8.39
Price/Book (MRQ)
3.38
Price/Sales (TTM)
5.53
EV/EBITDA
27.69
EV/Revenue
4.88
Dividend Yield
—
Book Value
$42.74
Free Cash Flow (FY2025)
$48.43M
Free Cash Flow Yield
0.86%

Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.